Antibodies to the soluble cellular antigens nuclear ribonucleoprotein (nRNP), Sm, SS-A, and SS-B occur frequently in the sera of patients with systemic lupus erythematosus (SLE). With the exception of anti-Sm' these antibodies are of limited diagnostic significance in SLE but may be important in defining 'clinical subsets,' particularly in relation to renal disease. It has been suggested that anti-nRNP and Sm are associated with relatively mild renal disease,23 and membranous nephritis commonly occurs in association with anti-Sm.3 Little information is available conceming associations between antibodies to SS-A or SS-B and patterns of renal involvement, though in one study anti-SS-A eluted from the kidneys of 2 patients with nephritis was thought to be of pathogenic importance. 4 The purpose of this study was to identify and quantitate antibodies to nRNP, Sm, SS-A, and SS-B in patients with SLE and to compare the serological findings with functional and histological manifestations of renal disease in SLE. Serial serum samples were examined in 4 patients in whom serial biopsies were also available in order to ascertain Accepted for publication 13 January 1982. Correspondence to Dr P. J. W. Venables. whether the antibody profile could be used to predict the evolution of the renal lesion which ultimately developed.
Material and methods
Sera from 48 patients fulfilling 4 or more preliminary American Rheumatism Association (ARA) criteria for SLEs were included in the study. In order to ensure a reasonably homogeneous population, patients with 'overlap syndromes' (many of whom fulfilled ARA criteria for SLE) were excluded if they fulfilled the criteria for 'mixed connective tissue disease' (MCTD) suggested by Bennett et 
Results
The frequency of the different antibody systems and their associations are shown in Table 1 . It can be seen that 65 % of the sera gave a precipitin reaction with one or more of the soluble cellular antigens nRNP, Sm, SS-A, and SS-B. Sixteen sera contained a defined single antibody specificity: 4 with anti-nRNP, one with anti-Sm, and 11 with anti-SS-A. In 15 sera 2 or more antibody systems were detected; 7 out of the 9 with anti-Sm also contained anti-nRNP and all 5 sera with anti-SS-B also contained anti-SS-A. The frequency of elevated anti-DNA antibodies (>25 U/ml) was similar in each serological subgroup ranging from 60% (anti-SS-B) to 77% (anti-Sm). 
